NCT06745778

Brief Summary

The goal of this observational study is to investigate the changes of LBB EGM during daily activities and overdrive pacing at the time of peri-implantation and up to 6-month follow-ups of ICD/CRT-D patients. The main question it aims to answer is: • Does the LBBP lead can provide accurate, stable, and valid EGM for ICD/CRT-D sensing and detection of ventricular tachyarrhythmia events? In each patient intracardiac EGMs of LBBP lead will be collected by ambulatory Holter monitor at the time of peri-implantation and up to 6-month follow-up. EGM collection will be collected at resting and walking conditions and overdrive pacing.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
1mo left

Started Feb 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Feb 2025Jun 2026

First Submitted

Initial submission to the registry

December 12, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 20, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

February 26, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

May 1, 2025

Status Verified

December 1, 2024

Enrollment Period

10 months

First QC Date

December 12, 2024

Last Update Submit

April 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • R-wave amplitude of LBB EGM

    Amplitude in millivolt

    At the enrollment, 3 months after enrollment and 6 months after enrollment

Secondary Outcomes (1)

  • EGM morphology-LVAT

    At the enrollment, 3 months after enrollment and 6 months after enrollment

Other Outcomes (6)

  • echocardiography results-LVEF

    At the enrollment and 6 months after enrollment

  • echocardiography results-SV

    At the enrollment and 6 months after enrollment

  • echocardiography results-LVEDV

    At the enrollment and 6 months after enrollment

  • +3 more other outcomes

Study Arms (1)

ICD or CRT-D patients who have received LBBP implantation

Patients' EGMs can be recorded by Holter DR220

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study selected two study site in China. One is a Tertiary A hospital in Zhejiang Province, and another is a hospital in Shanghai. Both of the two sites locate in south east of China. This study will enroll around 50 subjects who meet the inclusion and exclusion criteria from the ICD or CRT-D patients who have received LBBAP in the two hospitals.

You may qualify if:

  • Patients aged \>=18 yrs.
  • Patients indicated for ICD or CRT-D (primary or secondary prevention)
  • Patients who recently (\<=30 days) received ICD/CRT-D implantation with LBBP
  • Patients' EGM can be digitally recorded
  • Patients are willing to participate in the study and provide signed informed consent

You may not qualify if:

  • Patients received CIED upgrade or replacement with old pacing leads
  • Patients are pregnant
  • Patients participate in another study that will confound this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, 325000, China

RECRUITING

Shanghai Tongren Hospital

Shanghai, 200025, China

RECRUITING

Related Publications (1)

  • Ponnusamy SS, Ramalingam V, Ganesan V, Syed T, Kumar M, Mariappan S, Murugan S, Basil W, Vijayaraman P. Left bundle branch pacing-optimized implantable cardioverter-defibrillator (LOT-ICD) for cardiac resynchronization therapy: A pilot study. Heart Rhythm O2. 2022 Dec 16;3(6Part B):723-727. doi: 10.1016/j.hroo.2022.08.004. eCollection 2022 Dec.

MeSH Terms

Conditions

Tachycardia, VentricularVentricular Fibrillation

Condition Hierarchy (Ancestors)

TachycardiaArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2024

First Posted

December 20, 2024

Study Start

February 26, 2025

Primary Completion

December 31, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

May 1, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations